Benjamin F. Edwards & Company’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$52K Buy
391
+332
+563% +$40K ﹤0.01% 1319
2024
Q1
$6K Buy
59
+4
+7% +$359 ﹤0.01% 1832
2023
Q4
$4K Buy
55
+18
+49% +$1.14K ﹤0.01% 1919
2023
Q3
$2K Hold
37
﹤0.01% 1685
2023
Q2
$3K Hold
37
﹤0.01% 1645
2023
Q1
$2K Hold
37
﹤0.01% 1698
2022
Q4
$2K Buy
+37
New +$1.71K ﹤0.01% 1752
2019
Q4
Sell
-300
Closed -$7K 1947
2019
Q3
$7K Buy
+300
New +$6.39K ﹤0.01% 1504
2017
Q1
Sell
-675
Closed -$10K 1395
2016
Q4
$10K Buy
+675
New +$12.1K ﹤0.01% 947

Other funds holding THC

Benjamin F. Edwards & Company's THC Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Tenet Healthcare (THC) stake by 563% in Q2 2024, buying an estimated $40K and bringing the position to 391 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

Benjamin F. Edwards & Company first reported a position in THC in Q4 2016 and has held it in 9 quarters since. 529 funds tracked by Wall St. Rank hold THC as of Q2 2024.

  • Benjamin F. Edwards & Company held 391 shares of Tenet Healthcare worth $52K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 332 Tenet Healthcare shares in Q2 2024, an estimated $40K.
  • Tenet Healthcare made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1319 holding.
  • Benjamin F. Edwards & Company first reported a position in Tenet Healthcare in Q4 2016 and has held it in 9 quarters since.
  • 529 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.